In our cohort, only 8 patients (3.7%) had vitamin D levels <30 ng/mL with clear evidence of secondary hyperparathyroidism based on the laboratory normal range (PTH > 55 pg/mL). The gene discussed is PTH; the disease is secondary hyperparathyroidism.